TY  - JOUR
T1  - TRials to address efficacy of midodrine 18 years after it gains fda approval
AU  - Mitka M
Y1  - 2012/03/21
N1  - 10.1001/jama.2012.291
JO  - JAMA
SP  - 1124
EP  - 1127
VL  - 307
IS  - 11
N2  - 
This long journey to proving efficacy gives ammunition to critics of the FDA's drug approval process, who argue that regulatory loopholes allow medications whose true benefits are unknown to be available to patients.

SN  - 0098-7484
M3  - doi: 10.1001/jama.2012.291
UR  - http://dx.doi.org/10.1001/jama.2012.291
ER  -